These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3449121)

  • 1. Grading of dyspnoea and walking speed in cardiac disease and in chronic airflow obstruction.
    Warley AR; Finnegan OC; Nicholson EM; Laszlo G
    Br J Dis Chest; 1987 Oct; 81(4):349-55. PubMed ID: 3449121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.
    Wijkstra PJ; TenVergert EM; van der Mark TW; Postma DS; Van Altena R; Kraan J; Koëter GH
    Thorax; 1994 May; 49(5):468-72. PubMed ID: 8016768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin and perception of dyspnea in chronic airflow obstruction.
    Schiffman GL; Stansbury DW; Fischer CE; Sato RI; Light RW; Brown SE
    Am Rev Respir Dis; 1988 May; 137(5):1094-8. PubMed ID: 3195807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD.
    Wegner RE; Jörres RA; Kirsten DK; Magnussen H
    Eur Respir J; 1994 Apr; 7(4):725-9. PubMed ID: 8005256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway obstruction and chronic exertional dyspnoea in patients with persistent bronchial asthma.
    Filippelli M; Pacini F; Romagnoli I; Rosi E; Ottanelli R; Duranti R; Scano G
    Respir Med; 2000 Jul; 94(7):694-701. PubMed ID: 10926342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are "pink puffers" more breathless than "blue bloaters"?
    Johnson MA; Woodcock AA; Rehahn M; Geddes DM
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):179-82. PubMed ID: 6401519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of lung function tests with dyspnoea scale, 12 minute walking test and visual analogue scale in patients with COPD.
    Guleria R; Behera D; Jindal SK
    Indian J Chest Dis Allied Sci; 1989; 31(4):241-5. PubMed ID: 2638664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
    Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
    Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of dyspnoea in chronic obstructive pulmonary disease.
    Eakin EG; Kaplan RM; Ries AL
    Qual Life Res; 1993 Jun; 2(3):181-91. PubMed ID: 8401454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dyspnea and inspiratory effort capacity in COPD].
    Noseda A; Carpiaux JP; Schmerber J; Yernault JC
    Rev Mal Respir; 1993; 10(6):537-43. PubMed ID: 8122020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders.
    Hamilton AL; Killian KJ; Summers E; Jones NL
    Chest; 1996 Nov; 110(5):1255-63. PubMed ID: 8915230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.
    McGavin CR; Artvinli M; Naoe H; McHardy GJ
    Br Med J; 1978 Jul; 2(6132):241-3. PubMed ID: 678885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome.
    Eiser N; Denman WT; West C; Luce P
    Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention.
    Cloosterman SG; Hofland ID; van Schayck CP; Folgering HT
    Thorax; 1998 Sep; 53(9):768-74. PubMed ID: 10319059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
    Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effect of previous bronchial asthma on disability in chronic airflow obstruction.
    Laszlo G; Nicholson EM; Denison J; Goddard PR
    Lancet; 2000 Aug; 356(9231):737-8. PubMed ID: 11085697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease.
    Argyropoulou P; Patakas D; Koukou A; Vasiliadis P; Georgopoulos D
    Respiration; 1993; 60(4):216-20. PubMed ID: 8265878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of dyspnoea and respiratory function measurements in monitoring of asthma: a factor analysis.
    Grazzini M; Scano G; Foglio K; Duranti R; Bianchi L; Gigliotti E; Rosi E; Stendardi L; Ambrosino N
    Respir Med; 2001 Apr; 95(4):246-50. PubMed ID: 11316105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in smokers: focus on functional limitations rather than on lung function?
    Geijer RM; Sachs AP; Verheij TJ; Kerstjens HA; Kuyvenhoven MM; Hoes AW
    Br J Gen Pract; 2007 Jun; 57(539):477-82. PubMed ID: 17550673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.